This information is intended only for healthcare professionals resident in the United Kingdom

Prescribing Information (PI) for Elrexfio®▼ (elranatamab) Great Britain (GB) and Northern Ireland (NI)​​​​​

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

Great Britain

  • Elrexfio▼ (elranatamab) - 40 mg/mL solution for injection - PI for GB

Northern Ireland

  • Elrexfio▼ (elranatamab) - 40 mg/mL solution for injection - PI for NI

Elrexfio▼ (elranatamab) -  40 mg/mL solution for injection - PI for GB


Elrexfio▼ (elranatamab) -  40 mg/mL solution for injection - PI for NI

PP-L1A-GBR-0057 February 2024